Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

European Society
For Medical Oncology

Registration open to everyone
Registration open to everyone

Biliary Tract Cancer Webinar

How to apply the latest, best practice recommendations to your daily practice? Join this live discussion and get your questions answered by the ESMO Guidelines experts 

Register Now
Early registration until 6 March
Early registration until 6 March

ESMO Breast Cancer 2024

An event with the potential to shape the future of breast cancer care through cutting-edge research, clinical insights and multidisciplinary exchange

Register now
ESMO-MCBS 1000x1000


A validated and reproducible tool to assess the magnitude of clinical benefit for cancer medicines.

Discover more

Latest News

More Oncology News More Press Releases More Society Updates Read the ESMO Daily Reporter
More Oncology News
Press Releases Event Announcement

ESMO Asia Congress 2023, 1-3 December 2023, Singapore

The ESMO Asia Congress 2023 is the annual meeting to present and discuss the latest scientific and clinical advances across the entire field of oncology, of relevance at a global level and specifically for the Asia-Pacific region.

Press Releases ESMO Congress 2023 Press Release

The Right to be Forgotten: ESMO Calls on EU Countries to Ensure Equal Financial Rights for Cancer Survivors

As the ESMO Congress 2023 opens its doors in Madrid this week, ESMO calls all EU member states to act on the recently adopted final text of the EU Consumer Credits Directive by following their European neighbours Spain and France and guaranteeing cancer survivors seeking financial credit the so-called right to be forgotten after a period of five years following the end of their treatment

Press Releases ESMO Congress 2023 Press Release

Lung Cancer Treatment Research Enters a New Era

More people with non-small cell lung cancer (NSCLC) are likely to benefit from new drugs that target molecular alterations in tumour cells, with less need for chemotherapy, following results of multiple landmark clinical trials reported for the first time in late-breaking presentations at the ESMO Congress 2023  

More Press Releases
Society Updates Society Updates

2024 TAT Honorary Award Recipient Announced

The European Society for Medical Oncology (ESMO) has announced today that the 2024 ESMO TAT Honorary Award is bestowed to Funda Meric-Bernstam

Society Updates Society Updates

ESMO Congress 2023 Sets Strong Impulses for a Better Future in Oncology

After five days filled with practice-changing data, intense discussions and educational sessions addressing the needs and issues currently arising for oncology professionals and impacting patients with cancer worldwide, the ESMO Congress 2023 today sent home its more than 33,000 participants from 144 countries with plenty of food for thought and ample material to enrich their medical practice.

More Society Updates
Read the ESMO Daily Reporter

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.